Prescription drug samples - does this marketing strategy counteract policies for quality use of medicines?
Prescription drug samples - does this marketing strategy counteract policies for quality use of medicines?
复制标题
DOI：
10.1046/j.1365-2710.2003.00481.x
复制
发表时间：
2003-08-01
影响因子：
2
通讯作者：
Tett, SE
中科院分区：
文献类型：
--
作者：
Groves, KEM;Sketris, I;Tett, SE
制药行业用来营销其产品的处方药样品目前引起人们的关注，因为它们对处方的影响以及对消费者安全的潜在影响。关于处方药样品的使用和滥用，以及样品对旨在提高药物合理使用的卫生政策的影响的研究很少。这是处方药争论中的一个热门问题，随着成本的增加以及对优化药物使用的担忧日益增加。本手稿批判性地评估了迄今为止有关处方药样品的研究，讨论了传统营销理论背景下提出的问题，并提出了未来可能的替代方案。
Prescription drug samples, as used by the pharmaceutical industry to market their products, are of current interest because of their influence on prescribing, and their potential impact on consumer safety. Very little research has been conducted into the use and misuse of prescription drug samples, and the influence of samples on health policies designed to improve the rational use of medicines. This is a topical issue in the prescription drug debate, with increasing costs and increasing concerns about optimizing use of medicines. This manuscript critically evaluates the research that has been conducted to date about prescription drug samples, discusses the issues raised in the context of traditional marketing theory, and suggests possible alternatives for the future.